About Jubilant Pharmova Ltd: Company Profile & Business Model

Jubilant Pharmova Ltd

NSE: JUBLPHARMA BSE: 530019

₹980.35

(2.36)%

Tue, 03 Feb 2026, 07:11 am

MTF 5xInvest in Jubilant Pharmova Ltd with 5x Leverage Buy with MTF

Market Cap156.22B

PE Ratio32.59

Dividend0.51

Health Technology

Pharmaceuticals: Major

24.5K

About Jubilant Pharmova Ltd

Jubilant Pharmova in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1978

Headquarters

CEO

Shyam S Bhartia

Employees

Contact

Website

http://www.jubl.com

investors@jubl.com

Phone

91-5924-267200

Location

Bhartiagram Gajraula, , Amroha, Uttar Pradesh, 244223

Executives

Shyam S Bhartia

Chairman (Non-Executive)

Hari S Bhartia

Co-Chairman

Vivek Mehra

Independent Director

SUSHIL KUMAR ROONGTA

Independent Director

Priyavrat Bhartia

Managing Director

Arjun Shanker Bhartia

Joint Managing Director

Arun Seth

Independent Director

Shirish Gundopant Belapure

Independent Director

Ramakrishnan Arul

Whole-time Director

Harsh Mahajan

Independent Director

Shivpriya Nanda

Independent Director

Arvind Chokhany

Whole Time Director

Naresh Kapoor.

Company Sec. & Compli. Officer

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800